Agenus (AGEN) Competitors

Vanda Pharmaceuticals (NASDAQ:VNDA) and Agenus (NASDAQ:AGEN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, community ranking, dividends, analyst recommendations, institutional ownership and media sentiment.

Does the MarketBeat Community prefer VNDA or AGEN?

Vanda Pharmaceuticals received 70 more outperform votes than Agenus when rated by MarketBeat users. However, 69.39% of users gave Agenus an outperform vote while only 66.71% of users gave Vanda Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Vanda Pharmaceuticals	Outperform Votes 537 66.71%	Underperform Votes 268 33.29%
Agenus	Outperform Votes 467 69.39%	Underperform Votes 206 30.61%

Do institutionals & insiders have more ownership in VNDA or AGEN?

88.1% of Vanda Pharmaceuticals shares are held by institutional investors. Comparatively, 61.5% of Agenus shares are held by institutional investors. 8.9% of Vanda Pharmaceuticals shares are held by company insiders. Comparatively, 4.6% of Agenus shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Do analysts recommend VNDA or AGEN?

Vanda Pharmaceuticals presently has a consensus target price of $15.50, suggesting a potential upside of 220.25%. Agenus has a consensus target price of $10.00, suggesting a potential upside of 191.55%. Given Vanda Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe Vanda Pharmaceuticals is more favorable than Agenus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vanda Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Agenus	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Is VNDA or AGEN more profitable?

Vanda Pharmaceuticals has a net margin of -8.59% compared to Agenus' net margin of -145.89%. Agenus' return on equity of 0.00% beat Vanda Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vanda Pharmaceuticals	-8.59%	-3.02%	-2.52%
Agenus	-145.89%	N/A	-85.68%

Does the media favor VNDA or AGEN?

In the previous week, Agenus had 3 more articles in the media than Vanda Pharmaceuticals. MarketBeat recorded 5 mentions for Agenus and 2 mentions for Vanda Pharmaceuticals. Vanda Pharmaceuticals' average media sentiment score of 1.34 beat Agenus' score of 0.34 indicating that Vanda Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vanda Pharmaceuticals	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agenus	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more volatility and risk, VNDA or AGEN?

Vanda Pharmaceuticals has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Agenus has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500.

Which has stronger earnings and valuation, VNDA or AGEN?

Vanda Pharmaceuticals has higher revenue and earnings than Agenus. Vanda Pharmaceuticals is trading at a lower price-to-earnings ratio than Agenus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vanda Pharmaceuticals	$192.64M	1.47	$2.51M	-$0.28	-17.29
Agenus	$156.31M	0.51	-$245.76M	-$11.24	-0.31

Summary

Vanda Pharmaceuticals beats Agenus on 13 of the 18 factors compared between the two stocks.